Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | SHBG | P04278 | 1/20 | 0.50 |
| ▸ | MDH1 | P40925 | 13/20 | 0.46 |
| ▸ | MDH2 | P40926 | 13/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | APAF1 | O14727 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | FYN | P06241 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11110656 | 0.84 | CYP3A4 (0.60) | CYP3A4SMN1; SMN2SHBGMDH1MDH2 | |
| SCHEMBL23703947 | 0.84 | CYP3A4 (0.60) | CYP3A4SMN1; SMN2SHBGMDH1MDH2 | |
| SCHEMBL11125566 | 0.84 | CYP3A4 (0.70) | CYP3A4SMN1; SMN2SHBGMDH1MDH2 | |
| SCHEMBL11127186 | 0.82 | CYP3A4 (0.58) | CYP3A4SMN1; SMN2SHBGMDH1MDH2 | |
| SCHEMBL1257955 | 0.81 | SMN1; SMN2 (0.66) | CYP3A4SMN1; SMN2SHBGMDH1MDH2 | |
| SCHEMBL2129443 | 0.80 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1ALDH1A1LMNATP53 | |
| SCHEMBL12926334 | 0.80 | MEN1 (0.50) | CYP3A4SMN1; SMN2HIF1AMEN1ALDH1A1 | |
| SCHEMBL7166618 | 0.80 | CYP3A4 (0.59) | CYP3A4SMN1; SMN2SHBGMDH1MDH2 | |
| SCHEMBL4314095 | 0.80 | CYP3A4 (0.64) | CYP3A4SMN1; SMN2SHBGMDH1MDH2 | |
| SCHEMBL338553 | 0.79 | CYP3A4 (0.64) | CYP3A4SMN1; SMN2SHBGMDH1MDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12252574-B2 | Bis-phenyl-phenoxy polyolefin procatalysts having two anthracenyl ligands | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-03-18 | — | — | US | disclosed |
| EP-3601388-B1 | BIS-BIPHENYL-PHENOXY CATALYSTS FOR OLEFIN POLYMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-08-07 | — | — | EP | disclosed |
| US-20240084050-A1 | BIS-PHENYL-PHENOXY POLYOLEFIN PROCATALYSTS HAVING TWO ANTHRACENYL LIGANDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-03-14 | — | — | US | disclosed |
| EP-3844193-B1 | BIS-PHENYL-PHENOXY POLYOLEFIN PROCATALYSTS HAVING TWO ANTHRACENYL LIGANDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-01-03 | — | — | EP | disclosed |
| US-11401354-B2 | Bis-biphenyl-phenoxy catalysts for olefin polymerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-08-02 | — | — | US | disclosed |
| EP-3356430-B1 | A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-22 | — | — | EP | disclosed |
| US-20210309768-A1 | BIS-PHENYL-PHENOXY POLYOLEFIN PROCATALYSTS HAVING TWO ANTHRACENYL LIGANDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-10-07 | — | — | US | disclosed |
| US-20210309768-A1 | BIS-PHENYL-PHENOXY POLYOLEFIN PROCATALYSTS HAVING TWO ANTHRACENYL LIGANDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-10-07 | — | — | US | disclosed |
| EP-3844193-A1 | BIS-PHENYL-PHENOXY POLYOLEFIN PROCATALYSTS HAVING TWO ANTHRACENYL LIGANDS | Dow Global Technologies LLC (US) | 2021-07-07 | — | — | EP | disclosed |
| CN-108377649-B | Polymerization process for producing ethylene-based polymers | 陶氏环球技术有限责任公司 | 2021-04-23 | — | — | CN | disclosed |
| CN-112585172-A | Bis-phenylphenoxy polyolefin procatalysts with two anthracene-based ligands | 陶氏环球技术有限责任公司 | 2021-03-30 | — | — | CN | disclosed |
| US-10647797-B2 | Polymerization process for producing ethylene based polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-05-12 | — | — | US | disclosed |
| WO-2020047384-A1 | BIS-PHENYL-PHENOXY POLYOLEFIN PROCATALYSTS HAVING TWO ANTHRACENYL LIGANDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-03-05 | — | — | WO | disclosed |
| WO-2020047384-A1 | BIS-PHENYL-PHENOXY POLYOLEFIN PROCATALYSTS HAVING TWO ANTHRACENYL LIGANDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-03-05 | — | — | WO | disclosed |
| EP-3601388-A1 | BIS-BIPHENYL-PHENOXY CATALYSTS FOR OLEFIN POLYMERIZATION | Dow Global Technologies LLC (US) | 2020-02-05 | — | — | EP | disclosed |
| US-20180282452-A1 | A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-10-04 | — | — | US | disclosed |
| WO-2018183700-A1 | BIS-BIPHENYL-PHENOXY CATALYSTS FOR OLEFIN POLYMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-10-04 | — | — | WO | disclosed |
| EP-3356430-A1 | A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS | Dow Global Technologies LLC (US) | 2018-08-08 | — | — | EP | disclosed |
| EP-0102324-A2 | Lipids and surfactants in an aqueous medium | CIBA-GEIGY AG (CH) | 1984-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12252574-B2 | Bis-phenyl-phenoxy polyolefin procatalysts having two anthracenyl ligands | PARG, PARN, SOD1 | CYP3A4 558/4885SMN1; SMN2 3621/4885SHBG 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.